🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06904417
Enrolling by invitation Phase 1

Effect of Feldenkrais Method in Enhancing Postural Control for Patients with Diabetic Polyneuropathy

NCT06904417 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 1
Started
2025-03-30
Last updated
2025-04-01

Condition(s) studied

Diabetic Polyneuropathy

Investigational drug(s) / intervention(s)

The Feldenkrais-based interventionconventional balance training program

The Feldenkrais-based intervention: The Feldenkrais-based intervention consisted of guided awareness exercises aimed at improving movement patterns, proprioception, and postural control. Sessions were conducted twice weekly for 12 weeks, with each session lasting approximately 45 minutes

conventional balance training program: a conventional balance training program consisting of static and dynamic balance exercises, gait training, and strength-building activities, matched for session frequency and duration

Study summary

Background: Postural Control is a major complication of polyneuropathy, affecting patients suffering from diabetes mellitus. Purpose: To examine the effect of the Feldenkrais Method on dynamic balance, limits of stability and fear of falling in adults aged 45 to 60 years with diabetic polyneuropathy in the short and mid-term. Methods: A single-blinded, parallel, multicentric randomized control trial was conducted in two health centers. Adults aged 45 to 60 years with diabetic polyneuropathy and a history of falls or dynamic balance dysfunction were recruited from hospital databases and randomly assigned to either the study or control group. The study group received 16 sessions of Feldenkrais-based sensorimotor training. Both groups received diabetic foot care instructions and traditional balance exercises. Outcomes were measured at 3 and 6-month follow-up intervals. Dynamic balance was assessed using the Timed Up and Go (TUG) Test, limits of stability using Biodex and fear of falling with the Falls Efficacy Scale (FES).

Eligibility

Sex
ALL
Min age
45 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Individuals must have a diagnosis of Diabetic Polyneuropathy (DPN), confirmed by clinical examination and electrophysiological testing. * Participants must have stable glycemic control for at least three months prior to enrollment. * Individuals must be able to walk independently, with or without the use of an assistive device. Exclusion Criteria: * Individuals with severe visual or vestibular impairments are excluded from participation. * Participants with significant musculoskeletal disorders affecting gait are not eligible. * Individuals with severe cardiovascular or respiratory conditions are excluded. * Participants with cognitive impairments that prevent active participation are not eligible. * Individuals currently engaged in structured physical therapy or balance training programs are excluded.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cairo University Cairo Cairo Governorate

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06904417 on ClinicalTrials.gov ↗ ← All trials in Egypt